BioSpace News Archive

Business

BioLife Solutions Announces Third Quarter 2019 Financial Results

Updates 2019 financial guidance to reflect CBS acquisition, introduces preliminary 2020 revenue guidance of $50 to $56 million

November 12, 2019
·
12 min read
Alkermes’ Corporate Presentation to be Webcast at Upcoming Healthcare Conferences on Nov. 19, 2019

Alkermes plc announced that its corporate presentation will be webcast live at the Stifel 2019 Healthcare Conference on Tuesday, Nov. 19, 2019 at 1:15 p.m. ET from New York.

November 12, 2019
·
1 min read
Business

Marker Therapeutics Reports Third Quarter 2019 Operating and Financial Results

Marker Therapeutics, Inc. provided a corporate update and reported financial results for the third quarter ended September 30, 2019.

November 12, 2019
·
7 min read
Deals

BioLife Solutions Acquires Custom Biogenic Systems

Global leader in liquid nitrogen storage systems expected to support growth, diversify revenue and reduce evo® manufacturing costs

November 12, 2019
·
7 min read
Business

Cumberland Pharmaceuticals Reports 22% Revenue Growth In The Third Quarter

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology announced third quarter 2019 financial results with net revenues of $10.4 million, up 22% over the prior year quarter.

November 12, 2019
·
19 min read
Business

Regulus Therapeutics Reports Third Quarter 2019 Financial Results and Recent Updates

Receipt of Final Reports from the Chronic Toxicity Studies for Submission of Complete Response to Reinitiate the Multiple Ascending Dose Clinical Study for RGLS4326

November 12, 2019
·
9 min read
Business

Axcella Health Reports Third Quarter 2019 Financial Results and Provides Company Update

Completed enrollment of an ongoing non-IND clinical study of AXA1125/AXA1957 in more than 100 adult subjects with NAFLD

November 12, 2019
·
9 min read
Business

Senseonics Holdings, Inc. Reports Third Quarter 2019 Financial Results

Senseonics Holdings, Inc. reported financial results for the quarter ended September 30, 2019.

November 12, 2019
·
8 min read
Business

Equillium Announces Leadership Updates

Effective January 1, 2020 Bruce Steel will assume role of Chief Executive Officer, and Dan Bradbury will remain on the Board of Directors as Executive Chairman

November 12, 2019
·
7 min read
Deals

Replimune Announces Proposed Public Offering

Replimune Group, Inc., a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, announced a proposed public offering of up to 5,000,000 shares of its common stock.

November 12, 2019
·
4 min read